VEPSITAMAB

Investigational

Approval Year

Substance Class	Protein
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	ZR1EEO1ZLS
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

VEPSITAMAB

Official Name

English

IMMUNOGLOBULIN, BISPECIFIC, ANTI-(HUMAN MUCIN 17) (HUMAN MONOCLONAL MUC17_CD3_ALT2 SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HU

Preferred Name

English

vepsitamab [INN]

Common Name

English

Vepsitamab [WHO-DD]

Common Name

English

Showing 1 to 4 of 4 entries

Previous1Next

Show entries

Classification Tree

Code System

Code

Designated

FDA ORPHAN DRUG

741120

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Code System

Code

Type

Description

INN

11822

PRIMARY

SMS_ID

300000009420

PRIMARY

FDA UNII

ZR1EEO1ZLS

PRIMARY

CAS

2413453-53-7

PRIMARY

NCI_THESAURUS

C165588

PRIMARY

Showing 1 to 5 of 5 entries

Previous1Next

Subunit 0

Show entries

From	To
1_22	1_95
1_44	1_234
1_157	1_222
1_269	1_345
1_409	1_477

Showing 1 to 5 of 13 entries

Previous1 2 3Next

Show entries

Related Record

Type

Details


					ZR1EEO1ZLS

VEPSITAMAB

ACTIVE MOIETY

Amount:

Showing 1 to 1 of 1 entries

Previous1Next

Structural Modifications

Show entries

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID REMOVAL	[1_984]	C-TERMINUS			LYSINE	K3Z4F929H6

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL	ESTIMATED C4656H7144O1454N1258S35
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL	ESTIMATED 105000 Da (average)

Showing 1 to 2 of 2 entries

Previous1Next